N1-(1,2,3,4-tetrahydroacridin-9-yl)-N10-(((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)methyl)decane-1,10-diamine

ID: ALA5272055

Chembl Id: CHEMBL5272055

Max Phase: Preclinical

Molecular Formula: C35H53N3O5

Molecular Weight: 595.83

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)O[C@H]2[C@@H](O1)[C@@H](CNCCCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O[C@@H]1OC(C)(C)O[C@@H]12

Standard InChI:  InChI=1S/C35H53N3O5/c1-34(2)40-30-28(39-33-32(31(30)41-34)42-35(3,4)43-33)23-36-21-15-9-7-5-6-8-10-16-22-37-29-24-17-11-13-19-26(24)38-27-20-14-12-18-25(27)29/h11,13,17,19,28,30-33,36H,5-10,12,14-16,18,20-23H2,1-4H3,(H,37,38)/t28-,30+,31+,32-,33-/m1/s1

Standard InChI Key:  UUBTWFXYKFFDRF-MYOWWLDYSA-N

Alternative Forms

  1. Parent:

    ALA5272055

    ---

Associated Targets(non-human)

Ache Acetylcholinesterase (1323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bche Butyrylcholinesterase (210 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 595.83Molecular Weight (Monoisotopic): 595.3985AlogP: 6.63#Rotatable Bonds: 14
Polar Surface Area: 83.10Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.91CX LogP: 6.80CX LogD: 3.02
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.24Np Likeness Score: -0.02

References

1. Lopes JPB, Silva L, Lüdtke DS..  (2021)  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.,  12  (12.0): [PMID:35028560] [10.1039/D1MD00217A]

Source